JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
TRMCX
Price
$36.17
Change
-$0.17 (-0.47%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs TRMCX

Header iconJVMTX vs TRMCX Comparison
Open Charts JVMTX vs TRMCXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Value
Price$36.17
Change-$0.17 (-0.47%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs TRMCX Comparison Chart
Loading...
VS
JVMTX vs. TRMCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and TRMCX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. TRMCX (15.9B). TRMCX pays higher dividends than JVMTX: TRMCX (0.97) vs JVMTX (0.73). JVMTX was incepted earlier than TRMCX: JVMTX (11 years) vs TRMCX (28 years). TRMCX is a more actively managed with annual turnover of: 45.30 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than TRMCX: JVMTX (0) vs TRMCX (2500). TRMCX annual gain was more profitable for investors over the last year : 21.77 vs. JVMTX (19.27). JVMTX return over 5 years is better than : 43.64 vs. TRMCX (38.12).
JVMTXTRMCXJVMTX / TRMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years28 years-
Gain YTD11.01015.92969%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B15.9B147%
Annual Yield % from dividends0.730.9775%
Returns for 1 year19.2721.7789%
Returns for 3 years13.3810.45128%
Returns for 5 years43.6438.12114%
Returns for 10 years63.3420.20314%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems